DMD Advocates advising New Delhi Centre for Sight in an Investment Transaction from ChrysCapital

15 May 2024
  • DMD Advocates
  • Deal Reporting

DMD Advocates is advising New Delhi Centre for Sight (CFS), one of India’s leading eye care hospital chain, in an investment transaction from ChrysCapital, a private equity fund, wherein ChrysCapital has agreed to invest up to US$ 100 million by way of a primary infusion in CFS and through secondary acquisition of the entire stake held by the existing investor in CFS, i.e., Mahindra Holdings Limited, a wholly owned subsidiary of Mahindra & Mahindra Limited. DMD Advocates has been involved in drafting and negotiation of the transaction documents, as well as in conducting a vendor legal due diligence of CFS, its subsidiaries and the centres operated by CFS.

The transaction is led by Rashi Dhir (Senior Partner and Head of Corporate) along with Saiyam Chaturvedi (Associate Partner), Kajal Tandon (Principal Associate), Divay Rastogi (Principal Associate), Priyanka Hazarika (Senior Associate), Harshit Kumar (Associate), Arnav Mithal (Associate), and Srishti Pandey (Associate).

Aishwarya Gupta (Senior Associate), Astha Jindal (Associate), Aditi Kumari (Associate), Ayushi Mukherjee (Associate), Ela Bharti (Associate), Jasmine Brar (Associate), and Tarush Bhandari (Junior Associate) assisted the transaction team in the vendor due diligence exercise.

Other News

© DMD Advocates, 2023-24

Designed and maintained by Grapdes


This website has been designed only for the purpose of dissemination of basic information on DMD Advocates and is not meant for advertising or for soliciting work by DMD Advocates. The information provided through this website should not be construed as legal advice and is not intended to create any attorney-client relationship between DMD Advocates and the reader. Readers are requested to seek formal legal advice prior to acting upon any information provided herein.

I Agree